OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
952758

Alf Meem Yaa for Medical Supplies and Equipment Company SJSC

Medical Equipment, Supplies & DistributionVerified

The company maintains a strong liquidity position with a current ratio of 3.28, indicating that it has more than three times the current assets to cover its current liabilities. However, its operating cash flow is negative at -26,025,970 SAR, which may signal short-term cash flow challenges despite the high current ratio. The debt-to-equity ratio is 0.16, suggesting a conservative capital structure with limited leverage. Profitability metrics show a return on equity (ROE) of 19.54% and a return on assets (ROA) of 12.75%, both of which are strong and indicate efficient use of equity and assets to generate profit. The gross profit margin is 42.14% (128,487,180 SAR / 304,963,330 SAR), and the operating margin is 14.07% (42,902,190 SAR / 304,963,330 SAR), both of which are solid and suggest effective cost control and pricing power. The company operates in a single business segment, with no disclosed geographic diversification. All revenue is attributed to one segment, indicating a lack of diversification risk but also a concentration risk if demand in this segment declines. Looking ahead, the company is expected to maintain its revenue trajectory, with no specific growth or decline percentages provided in the outlook. However, the negative operating cash flow and the presence of long-term debt (27,773,840 SAR) may pose challenges to sustaining growth without additional financing. The risk assessment highlights a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is low, with no near-term pressure expected, and no recent dilutive events reported. Analysts have provided a mean recommendation of 2.00, indicating a "Buy" rating, with one analyst recommending a buy and none recommending a strong buy or hold. Recent events include the latest financial filing, which shows a net income of 35,008,810 SAR and a free cash flow of 21,438,800 SAR. No recent earnings call transcripts or major corporate events were disclosed in the available data.

30-day price · 9527-13.50 (-15.3%)
Low$70.00High$88.50Close$75.00As of14 May, 00:00 UTC
Profile
CompanyAlf Meem Yaa for Medical Supplies and Equipment Company SJSC
Ticker9527.SE
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Alf Meem Yaa for Medical Supplies and Equipment Company SJSC provides medical equipment and supplies, primarily generating revenue through the distribution and sale of healthcare products.

Classification. The company is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

The company maintains a strong liquidity position with a current ratio of 3.28, indicating that it has more than three times the current assets to cover its current liabilities. However, its operating cash flow is negative at -26,025,970 SAR, which may signal short-term cash flow challenges despite the high current ratio. The debt-to-equity ratio is 0.16, suggesting a conservative capital structure with limited leverage. Profitability metrics show a return on equity (ROE) of 19.54% and a return on assets (ROA) of 12.75%, both of which are strong and indicate efficient use of equity and assets to generate profit. The gross profit margin is 42.14% (128,487,180 SAR / 304,963,330 SAR), and the operating margin is 14.07% (42,902,190 SAR / 304,963,330 SAR), both of which are solid and suggest effective cost control and pricing power. The company operates in a single business segment, with no disclosed geographic diversification. All revenue is attributed to one segment, indicating a lack of diversification risk but also a concentration risk if demand in this segment declines. Looking ahead, the company is expected to maintain its revenue trajectory, with no specific growth or decline percentages provided in the outlook. However, the negative operating cash flow and the presence of long-term debt (27,773,840 SAR) may pose challenges to sustaining growth without additional financing. The risk assessment highlights a medium liquidity risk due to the negative net cash position after subtracting total debt. The dilution risk is low, with no near-term pressure expected, and no recent dilutive events reported. Analysts have provided a mean recommendation of 2.00, indicating a "Buy" rating, with one analyst recommending a buy and none recommending a strong buy or hold. Recent events include the latest financial filing, which shows a net income of 35,008,810 SAR and a free cash flow of 21,438,800 SAR. No recent earnings call transcripts or major corporate events were disclosed in the available data.
Key takeaways
  • The company has a strong ROE of 19.54% and ROA of 12.75%, indicating efficient use of equity and assets.
  • A current ratio of 3.28 suggests a strong liquidity position, but the negative operating cash flow may signal short-term cash flow challenges.
  • The company operates in a single business segment with no geographic diversification, indicating a concentration risk.
  • Analysts have provided a "Buy" rating, with a mean recommendation of 2.00 and one analyst recommending a buy.
  • The debt-to-equity ratio is 0.16, indicating a conservative capital structure with limited leverage.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue$305.0M
Gross profit$128.5M
Operating income$42.9M
Net income$35.0M
R&D
SG&A
D&A
SBC
Operating cash flow-$26.0M
CapEx-$1.2M
Free cash flow$21.4M
Total assets$274.5M
Total liabilities$95.3M
Total equity$179.2M
Cash & equivalents
Long-term debt$27.8M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$179.2M
Net cash-$27.8M
Current ratio3.3
Debt/Equity0.2
ROA12.8%
ROE19.5%
Cash conversion-74.0%
CapEx/Revenue-0.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
Metric9527Activity
Op margin14.1%3.9% medp25 -31.3% · p75 14.4%above median
Net margin11.5%2.4% medp25 -30.5% · p75 11.1%top quartile
Gross margin42.1%46.7% medp25 28.2% · p75 63.1%below median
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-0.4%-4.8% medp25 -11.6% · p75 -2.4%top quartile
Debt / equity16.0%17.9% medp25 2.7% · p75 52.2%below median
Observations
IR observations
Mean price target184.00 SAR
Median price target184.00 SAR
High price target184.00 SAR
Low price target184.00 SAR
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate8.40 SAR
Last actual EPS5.00 SAR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-14 00:46 UTC#d86cb0f4
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 05:06 UTCJob: 58946fe1